Tine Willum Hansen
Overview
Explore the profile of Tine Willum Hansen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
67
Citations
1296
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stougaard E, Curovic V, Hansen T
Diabetes Ther
. 2025 Mar;
PMID: 40088324
Combination therapy is a cornerstone of modern type 2 diabetes management, extending beyond traditional goals of glucose, blood pressure, and lipid control to focus on therapies protecting the heart and...
2.
Hansen T, Ripa R
Diabetes Ther
. 2025 Mar;
PMID: 40048055
Microangiopathy is a key complication of diabetes, adversely effecting several organs including the heart, kidneys, eyes, and nerves. This review focuses on myocardial microvascular dysfunction, a condition characterized by altered...
3.
Heinrich N, Pedersen R, Vestergaard M, Lindberg U, Andersen U, Haddock B, et al.
J Diabetes Complications
. 2024 Dec;
39(2):108923.
PMID: 39647261
Background And Hypothesis: The kidneys may be susceptible to ectopic fat and its lipotoxic effects, disposing them to chronic kidney disease (CKD) in type 2 diabetes (T2D). We investigated whether...
4.
5.
Stougaard E, Tougaard N, Sivalingam S, Hansen C, Storling J, Hansen T, et al.
J Diabetes Complications
. 2024 Oct;
38(12):108892.
PMID: 39471704
Aims: To estimate whether a mix of pre- and probiotics would strengthen the gut barrier and protect the kidneys in individuals with type 1 diabetes and albuminuria. Methods: Randomized, placebo-controlled,...
6.
Wasehuus V, Curovic V, Tofte N, Lindhardt M, Currie G, Delles C, et al.
Diabetes Obes Metab
. 2024 Oct;
27(1):387-393.
PMID: 39468380
Aims: This study aimed to explore the effect of discontinuation of long-term spironolactone treatment on markers of kidney function in individuals with type 2 diabetes (T2D) at high risk of...
7.
Kufaishi H, Bertoli D, Kornum D, Ranjan A, Norgaard K, Krogh K, et al.
Diabetes Technol Ther
. 2024 Oct;
27(1):52-59.
PMID: 39446990
Autonomic neuropathy is associated with dysglycemia that is difficult to control. We investigated if transcutaneous vagus nerve stimulation (tVNS) could improve glycemic levels. We randomized 145 individuals with type 1...
8.
Friis Bryde Nielsen C, Thysen S, Bach Kampmann F, Hansen T, Jorgensen N, Tofte N, et al.
Diabetes Obes Metab
. 2024 Oct;
27(1):348-356.
PMID: 39434445
Background And Aim: Vitamin K deficiency is common in persons with kidney disease, which is a known complication of diabetes. We aimed to assess the association of vitamin K status...
9.
Curovic V, Stougaard E, Hansen T
Diabetes Obes Metab
. 2024 Oct;
26 Suppl 6:22-32.
PMID: 39410663
The global prevalence of chronic kidney disease (CKD) is approximately 9%. CKD is predicted to become the fifth largest global cause of death by 2040. Moreover, CKD causes disability, diminished...
10.
Rossing P, Hansen T, Kumler T
Diabetes Obes Metab
. 2024 Jul;
26 Suppl 6:13-21.
PMID: 38982587
Chronic kidney disease (CKD) currently affects approximately 850 million people globally and is continuing to increase in prevalence as well as in importance as a cause of death. The excess...